LT4230B - Novel cell systems having specific interaction of peptide binding pairs - Google Patents

Novel cell systems having specific interaction of peptide binding pairs Download PDF

Info

Publication number: LT4230B
Authority: LT; Lithuania
Prior art keywords: peptide; host cell; cell; protein; binding
Prior art date: 1994-06-14

Application number

LT97-004A

Other languages

English (en)

Lithuanian (lt)

Other versions

LT97004A (en

Inventor

Kathleen H Young

Bradley A Ozenberger

Original Assignee

American Cyanamid Company A Ma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-14

Filing date

1997-01-13

Publication date

1997-10-27

1997-01-13 Application filed by American Cyanamid Company A Ma filed Critical American Cyanamid Company A Ma

1997-07-25 Publication of LT97004A publication Critical patent/LT97004A/xx

1997-10-27 Publication of LT4230B publication Critical patent/LT4230B/lt

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 200
230000027455 binding Effects 0.000 title claims abstract description 121
230000003993 interaction Effects 0.000 title claims description 27
108090000623 proteins and genes Proteins 0.000 claims abstract description 190
102000004169 proteins and genes Human genes 0.000 claims abstract description 91
102000037865 fusion proteins Human genes 0.000 claims abstract description 73
108020001507 fusion proteins Proteins 0.000 claims abstract description 73
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 claims abstract description 65
238000000034 method Methods 0.000 claims abstract description 46
238000012360 testing method Methods 0.000 claims abstract description 41
230000004568 DNA-binding Effects 0.000 claims abstract description 33
230000035772 mutation Effects 0.000 claims abstract description 9
239000013611 chromosomal DNA Substances 0.000 claims abstract description 7
238000012217 deletion Methods 0.000 claims abstract description 6
230000037430 deletion Effects 0.000 claims abstract description 6
108700008625 Reporter Genes Proteins 0.000 claims abstract 3
210000004027 cell Anatomy 0.000 claims description 149
102000005962 receptors Human genes 0.000 claims description 101
108020003175 receptors Proteins 0.000 claims description 101
239000003446 ligand Substances 0.000 claims description 70
102000004196 processed proteins & peptides Human genes 0.000 claims description 70
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 35
235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 35
230000000694 effects Effects 0.000 claims description 32
239000013612 plasmid Substances 0.000 claims description 27
108010057464 Prolactin Proteins 0.000 claims description 22
102100024819 Prolactin Human genes 0.000 claims description 21
229940097325 prolactin Drugs 0.000 claims description 20
102100039556 Galectin-4 Human genes 0.000 claims description 19
239000002299 complementary DNA Substances 0.000 claims description 19
239000006152 selective media Substances 0.000 claims description 18
108010001515 Galectin 4 Proteins 0.000 claims description 14
238000003556 assay Methods 0.000 claims description 13
229940088597 hormone Drugs 0.000 claims description 12
210000005253 yeast cell Anatomy 0.000 claims description 12
239000005556 hormone Substances 0.000 claims description 11
230000008859 change Effects 0.000 claims description 7
230000001419 dependent effect Effects 0.000 claims description 7
230000006870 function Effects 0.000 claims description 7
239000003112 inhibitor Substances 0.000 claims description 7
230000001131 transforming effect Effects 0.000 claims description 7
239000003102 growth factor Substances 0.000 claims description 6
108010067225 Cell Adhesion Molecules Proteins 0.000 claims description 5
102000016289 Cell Adhesion Molecules Human genes 0.000 claims description 5
108020004414 DNA Proteins 0.000 claims description 5
102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 5
108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 5
101000608765 Homo sapiens Galectin-4 Proteins 0.000 claims description 5
230000003362 replicative effect Effects 0.000 claims description 5
230000002103 transcriptional effect Effects 0.000 claims description 5
108010078791 Carrier Proteins Proteins 0.000 claims description 4
108010058643 Fungal Proteins Proteins 0.000 claims description 4
239000000427 antigen Substances 0.000 claims description 4
108091007433 antigens Proteins 0.000 claims description 4
102000036639 antigens Human genes 0.000 claims description 4
230000002538 fungal effect Effects 0.000 claims description 4
239000000122 growth hormone Substances 0.000 claims description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 4
230000003834 intracellular effect Effects 0.000 claims description 4
238000012546 transfer Methods 0.000 claims description 4
108020004635 Complementary DNA Proteins 0.000 claims description 3
102000004127 Cytokines Human genes 0.000 claims description 3
108090000695 Cytokines Proteins 0.000 claims description 3
102000012673 Follicle Stimulating Hormone Human genes 0.000 claims description 3
108010079345 Follicle Stimulating Hormone Proteins 0.000 claims description 3
108010051696 Growth Hormone Proteins 0.000 claims description 3
108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 3
108020005497 Nuclear hormone receptor Proteins 0.000 claims description 3
102000007399 Nuclear hormone receptor Human genes 0.000 claims description 3
102100038803 Somatotropin Human genes 0.000 claims description 3
108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims description 3
238000010804 cDNA synthesis Methods 0.000 claims description 3
238000001514 detection method Methods 0.000 claims description 3
229940028334 follicle stimulating hormone Drugs 0.000 claims description 3
108010045747 interleukin 3 receptor-like molecule Proteins 0.000 claims description 3
238000012544 monitoring process Methods 0.000 claims description 3
108020004017 nuclear receptors Proteins 0.000 claims description 3
108091008875 B cell receptors Proteins 0.000 claims description 2
102100027207 CD27 antigen Human genes 0.000 claims description 2
102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 claims description 2
102000003951 Erythropoietin Human genes 0.000 claims description 2
108090000394 Erythropoietin Proteins 0.000 claims description 2
108010087819 Fc receptors Proteins 0.000 claims description 2
102000009109 Fc receptors Human genes 0.000 claims description 2
102000008946 Fibrinogen Human genes 0.000 claims description 2
108010049003 Fibrinogen Proteins 0.000 claims description 2
102100037362 Fibronectin Human genes 0.000 claims description 2
108010067306 Fibronectins Proteins 0.000 claims description 2
108060003199 Glucagon Proteins 0.000 claims description 2
102000051325 Glucagon Human genes 0.000 claims description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 2
239000000095 Growth Hormone-Releasing Hormone Substances 0.000 claims description 2
108010013990 Guanylate Cyclase-Coupled Receptors Proteins 0.000 claims description 2
102000017178 Guanylate Cyclase-Coupled Receptors Human genes 0.000 claims description 2
108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 claims description 2
241000238631 Hexapoda Species 0.000 claims description 2
101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 2
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 2
101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 2
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 2
102000004877 Insulin Human genes 0.000 claims description 2
108090001061 Insulin Proteins 0.000 claims description 2
108010050904 Interferons Proteins 0.000 claims description 2
102000014150 Interferons Human genes 0.000 claims description 2
108090001007 Interleukin-8 Proteins 0.000 claims description 2
102000015696 Interleukins Human genes 0.000 claims description 2
108010063738 Interleukins Proteins 0.000 claims description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
108060001084 Luciferase Proteins 0.000 claims description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 2
108010003044 Placental Lactogen Proteins 0.000 claims description 2
239000000381 Placental Lactogen Substances 0.000 claims description 2
101150005828 SWI5 gene Proteins 0.000 claims description 2
241000235347 Schizosaccharomyces pombe Species 0.000 claims description 2
102100037505 Secretin Human genes 0.000 claims description 2
108010086019 Secretin Proteins 0.000 claims description 2
108090000184 Selectins Proteins 0.000 claims description 2
102000003800 Selectins Human genes 0.000 claims description 2
102100022831 Somatoliberin Human genes 0.000 claims description 2
101710142969 Somatoliberin Proteins 0.000 claims description 2
102000013275 Somatomedins Human genes 0.000 claims description 2
102000015215 Stem Cell Factor Human genes 0.000 claims description 2
108010039445 Stem Cell Factor Proteins 0.000 claims description 2
108091008874 T cell receptors Proteins 0.000 claims description 2
102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 2
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 2
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 2
108010061174 Thyrotropin Proteins 0.000 claims description 2
102000011923 Thyrotropin Human genes 0.000 claims description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 2
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 2
230000003115 biocidal effect Effects 0.000 claims description 2
210000004204 blood vessel Anatomy 0.000 claims description 2
230000000295 complement effect Effects 0.000 claims description 2
230000004069 differentiation Effects 0.000 claims description 2
230000003511 endothelial effect Effects 0.000 claims description 2
229940105423 erythropoietin Drugs 0.000 claims description 2
229940012952 fibrinogen Drugs 0.000 claims description 2
210000002950 fibroblast Anatomy 0.000 claims description 2
229960004666 glucagon Drugs 0.000 claims description 2
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 2
230000003394 haemopoietic effect Effects 0.000 claims description 2
-1 hematopoietic factor Proteins 0.000 claims description 2
239000002955 immunomodulating agent Substances 0.000 claims description 2
229940121354 immunomodulator Drugs 0.000 claims description 2
230000002584 immunomodulator Effects 0.000 claims description 2
230000002401 inhibitory effect Effects 0.000 claims description 2
229940125396 insulin Drugs 0.000 claims description 2
102000006495 integrins Human genes 0.000 claims description 2
108010044426 integrins Proteins 0.000 claims description 2
229940096397 interleukin-8 Drugs 0.000 claims description 2
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims description 2
101150066555 lacZ gene Proteins 0.000 claims description 2
208000032839 leukemia Diseases 0.000 claims description 2
230000029849 luteinization Effects 0.000 claims description 2
210000005036 nerve Anatomy 0.000 claims description 2
239000003076 neurotropic agent Substances 0.000 claims description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 2
AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 claims description 2
229960002101 secretin Drugs 0.000 claims description 2
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 claims description 2
230000035945 sensitivity Effects 0.000 claims description 2
239000000126 substance Substances 0.000 claims description 2
108010050014 systemin Proteins 0.000 claims description 2
HOWHQWFXSLOJEF-MGZLOUMQSA-N systemin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H]2N(CCC2)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CCC1 HOWHQWFXSLOJEF-MGZLOUMQSA-N 0.000 claims description 2
229960000874 thyrotropin Drugs 0.000 claims description 2
230000001748 thyrotropin Effects 0.000 claims description 2
102000003390 tumor necrosis factor Human genes 0.000 claims description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
230000002792 vascular Effects 0.000 claims description 2
241000228212 Aspergillus Species 0.000 claims 1
102000014914 Carrier Proteins Human genes 0.000 claims 1
102000004890 Interleukin-8 Human genes 0.000 claims 1
102000004140 Oncostatin M Human genes 0.000 claims 1
108090000630 Oncostatin M Proteins 0.000 claims 1
DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 claims 1
241000235648 Pichia Species 0.000 claims 1
102000005421 acetyltransferase Human genes 0.000 claims 1
108020002494 acetyltransferase Proteins 0.000 claims 1
238000013096 assay test Methods 0.000 claims 1
230000001886 ciliary effect Effects 0.000 claims 1
210000003527 eukaryotic cell Anatomy 0.000 claims 1
230000002519 immonomodulatory effect Effects 0.000 claims 1
229940079322 interferon Drugs 0.000 claims 1
102000014187 peptide receptors Human genes 0.000 claims 1
108010011903 peptide receptors Proteins 0.000 claims 1
238000012216 screening Methods 0.000 abstract description 11
150000001875 compounds Chemical class 0.000 description 33
108010002519 Prolactin Receptors Proteins 0.000 description 21
230000004913 activation Effects 0.000 description 18
230000004927 fusion Effects 0.000 description 17
239000013598 vector Substances 0.000 description 17
108091034117 Oligonucleotide Proteins 0.000 description 16
102100029000 Prolactin receptor Human genes 0.000 description 15
230000012010 growth Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
239000012634 fragment Substances 0.000 description 11
238000006471 dimerization reaction Methods 0.000 description 10
230000000875 corresponding effect Effects 0.000 description 7
101100353517 Caenorhabditis elegans pas-2 gene Proteins 0.000 description 6
230000010261 cell growth Effects 0.000 description 6
239000000813 peptide hormone Substances 0.000 description 6
230000003389 potentiating effect Effects 0.000 description 6
108091007914 CDKs Proteins 0.000 description 5
102000003903 Cyclin-dependent kinases Human genes 0.000 description 5
108090000266 Cyclin-dependent kinases Proteins 0.000 description 5
230000003213 activating effect Effects 0.000 description 5
102000023732 binding proteins Human genes 0.000 description 5
108091008324 binding proteins Proteins 0.000 description 5
108010057085 cytokine receptors Proteins 0.000 description 5
102000003675 cytokine receptors Human genes 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
101150009006 HIS3 gene Proteins 0.000 description 4
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 4
101150050575 URA3 gene Proteins 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
238000010586 diagram Methods 0.000 description 4
239000000539 dimer Substances 0.000 description 4
230000009977 dual effect Effects 0.000 description 4
239000013613 expression plasmid Substances 0.000 description 4
230000000670 limiting effect Effects 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
230000009870 specific binding Effects 0.000 description 4
102100020948 Growth hormone receptor Human genes 0.000 description 3
101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 3
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 3
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 3
230000010799 Receptor Interactions Effects 0.000 description 3
108050002653 Retinoblastoma protein Proteins 0.000 description 3
230000004075 alteration Effects 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
238000010367 cloning Methods 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
230000001817 pituitary effect Effects 0.000 description 3
230000006916 protein interaction Effects 0.000 description 3
230000004850 protein–protein interaction Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
238000002805 secondary assay Methods 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000052510 DNA-Binding Proteins Human genes 0.000 description 2
101710096438 DNA-binding protein Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
108020005038 Terminator Codon Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000008272 agar Substances 0.000 description 2
238000004166 bioassay Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000036755 cellular response Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
230000002950 deficient Effects 0.000 description 2
108010005905 delta-hGHR Proteins 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
239000002773 nucleotide Substances 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
230000004044 response Effects 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
239000013605 shuttle vector Substances 0.000 description 2
230000011664 signaling Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
108091006106 transcriptional activators Proteins 0.000 description 2
238000010396 two-hybrid screening Methods 0.000 description 2
239000002023 wood Substances 0.000 description 2
NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 description 1
102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
101150008604 CAN1 gene Proteins 0.000 description 1
101100490563 Caenorhabditis elegans adr-1 gene Proteins 0.000 description 1
101100001271 Caenorhabditis elegans ahr-1 gene Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
241001432959 Chernes Species 0.000 description 1
206010061765 Chromosomal mutation Diseases 0.000 description 1
108010000063 Ciliary Neurotrophic Factor Receptor Proteins 0.000 description 1
102000016989 Ciliary Neurotrophic Factor Receptor Human genes 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
230000010682 Fusion Protein Interactions Effects 0.000 description 1
108091006027 G proteins Proteins 0.000 description 1
102000030782 GTP binding Human genes 0.000 description 1
108091000058 GTP-Binding Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102400001066 Growth hormone-binding protein Human genes 0.000 description 1
101800000194 Growth hormone-binding protein Proteins 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
101001042362 Homo sapiens Leukemia inhibitory factor receptor Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102100036721 Insulin receptor Human genes 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
102000001617 Interferon Receptors Human genes 0.000 description 1
108010054267 Interferon Receptors Proteins 0.000 description 1
102100026236 Interleukin-8 Human genes 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
102000016304 Origin Recognition Complex Human genes 0.000 description 1
108010067244 Origin Recognition Complex Proteins 0.000 description 1
241001635529 Orius Species 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
241000224016 Plasmodium Species 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
101001075257 Rattus norvegicus Growth hormone receptor Proteins 0.000 description 1
101001109695 Rattus norvegicus Nuclear receptor subfamily 4 group A member 1 Proteins 0.000 description 1
102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
241000235343 Saccharomycetales Species 0.000 description 1
241000235346 Schizosaccharomyces Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108010068542 Somatotropin Receptors Proteins 0.000 description 1
108010085012 Steroid Receptors Proteins 0.000 description 1
102000007451 Steroid Receptors Human genes 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
DQPBABKTKYNPMH-UHFFFAOYSA-M amino sulfate Chemical compound NOS([O-])(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-M 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
108010066540 copper thionein Proteins 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000009510 drug design Methods 0.000 description 1
UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
230000002357 endometrial effect Effects 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229940011871 estrogen Drugs 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
230000004992 fission Effects 0.000 description 1
MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
108091009655 growth hormone receptor binding proteins Proteins 0.000 description 1
210000004349 growth plate Anatomy 0.000 description 1
239000000185 hemagglutinin Substances 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000008611 intercellular interaction Effects 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000008606 intracellular interaction Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
108020001756 ligand binding domains Proteins 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
239000002395 mineralocorticoid Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000017095 negative regulation of cell growth Effects 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
238000010397 one-hybrid screening Methods 0.000 description 1
210000004681 ovum Anatomy 0.000 description 1
101150047627 pgk gene Proteins 0.000 description 1
239000003016 pheromone Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
230000006461 physiological response Effects 0.000 description 1
229940037129 plain mineralocorticoids for systemic use Drugs 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000000047 product Substances 0.000 description 1
229960003387 progesterone Drugs 0.000 description 1
239000000186 progesterone Substances 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
239000000007 protein synthesis inhibitor Substances 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
239000002464 receptor antagonist Substances 0.000 description 1
229940044551 receptor antagonist Drugs 0.000 description 1
102000027426 receptor tyrosine kinases Human genes 0.000 description 1
108091008598 receptor tyrosine kinases Proteins 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
229930002330 retinoic acid Natural products 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
108010033419 somatotropin-binding protein Proteins 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
229960001727 tretinoin Drugs 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Toxicology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Mobile Radio Communication Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LT97-004A 1994-06-14 1997-01-13 Novel cell systems having specific interaction of peptide binding pairs LT4230B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/259,609 US5989808A (en)	1994-06-14	1994-06-14	Identification of compounds affecting specific interaction of peptide binding pairs

Publications (2)

Publication Number	Publication Date
LT97004A LT97004A (en)	1997-07-25
LT4230B true LT4230B (en)	1997-10-27

Family

ID=22985626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LT97-004A LT4230B (en)	1994-06-14	1997-01-13	Novel cell systems having specific interaction of peptide binding pairs

Country Status (18)

Country	Link
US (3)	US5989808A (de)
EP (1)	EP0765389B1 (de)
AT (1)	ATE245189T1 (de)
AU (1)	AU706173B2 (de)
CA (1)	CA2195083A1 (de)
DE (1)	DE69531302T2 (de)
DK (1)	DK0765389T3 (de)
ES (1)	ES2202366T3 (de)
GE (1)	GEP20022619B (de)
IL (1)	IL114118A0 (de)
LT (1)	LT4230B (de)
LV (1)	LV11906B (de)
NZ (1)	NZ287372A (de)
PT (1)	PT765389E (de)
RU (1)	RU2208646C2 (de)
SI (1)	SI9520073B (de)
WO (1)	WO1995034646A1 (de)
ZA (1)	ZA954892B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7226761B2 (en) *	1992-11-05	2007-06-05	Danisco Sweeteners Oy	Manufacture of five-carbon sugars and sugar alcohols
US6972193B1 (en) *	1993-02-12	2005-12-06	Board Of Trustees Of Leland Stanford Junior University	Regulated transcription of targeted genes and other biological events
US6891021B2 (en)	1993-02-12	2005-05-10	Board Of Trustees Of The Leland Stanford Junior University	Regulated apoptosis
US6770446B1 (en) *	1994-06-14	2004-08-03	Wyeth	Cell systems having specific interaction of peptide binding pairs
US5610015A (en) *	1995-03-23	1997-03-11	Wisconsin Alumni Research Foundation	System to detect protein-RNA interactions
ATE352638T1 (de) *	1995-04-11	2007-02-15	Gen Hospital Corp	REVERSE ßTWO-HYBRIDß-SYSTEME
US6423824B1 (en)	1995-06-07	2002-07-23	Biogen, Inc.	CAIP-like gene family
US6171800B1 (en)	1995-06-07	2001-01-09	Biogen, Inc.	Method of making and binding CAIP polypeptides
US5837844A (en) *	1995-06-07	1998-11-17	Biogen, Inc.	CAIP-like gene family
ES2183166T3 (es) *	1996-04-26	2003-03-16	Massachusetts Inst Technology	Ensayo de cribado por triple hibrido.
EP1241265A3 (de) *	1996-04-26	2004-02-18	Massachusetts Institute Of Technology	Screening-Verfahren für kleine Liganden
US6696251B1 (en)	1996-05-31	2004-02-24	Board Of Trustees Of The University Of Illinois	Yeast cell surface display of proteins and uses thereof
WO1997049808A1 (en) *	1996-06-27	1997-12-31	Biogen, Inc.	The caip-like gene family
FR2761697B1 (fr) *	1997-04-03	1999-05-28	Inst Nat Sante Rech Med	Methodes de detection d'interactions entre plusieurs proteines
DE19715683C2 (de) *	1997-04-15	1999-11-11	Max Planck Gesellschaft	Neue Reportervektoren für One-Hybrid und Two-Hybrid Systeme
US7005295B1 (en)	1997-04-16	2006-02-28	Wyeth	β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en)	1997-04-16	2004-09-07	American Home Products Corp.	β-amyloid peptide-binding proteins and polynucleotides encoding the same
ES2181197T3 (es)	1997-04-25	2003-02-16	Wyeth Corp	Isoformas de mort1 neuronal.
US6479653B1 (en)	1997-08-26	2002-11-12	Ariad Gene Therapeutics, Inc.	Compositions and method for regulation of transcription
JP4296608B2 (ja) *	1997-08-27	2009-07-15	田辺三菱製薬株式会社	Ｐｐａｒのアゴニスト及びアンタゴニストのスクリーニング方法
EP1149920A1 (de) *	1997-10-15	2001-10-31	Diversa, Inc.	Screening fÜr neue Verbindungen, die biologische Interaktionen regulieren
US6846627B2 (en)	1997-10-15	2005-01-25	Diversa Corporation	Screening for novel compounds which regulate biological interactions
US6261842B1 (en)	1997-10-23	2001-07-17	Wisconsin Alumni Research Foundation	Microorganism genomics, compositions and methods related thereto
CA2309763A1 (en) *	1997-11-14	1999-05-27	Roche Diagnostics Corporation	Variable region fusion peptides that form effector complexes in the presence of antigen
WO1999035282A1 (en)	1998-01-09	1999-07-15	Tvw Telethon Institute For Child Health Research	Peptide detection method
EP0974649A1 (de) *	1998-06-22	2000-01-26	Universität Zürich	Screening-System
US7166475B2 (en)	1999-02-26	2007-01-23	Cyclacel Ltd.	Compositions and methods for monitoring the modification state of a pair of polypeptides
GB9907687D0 (en) *	1999-04-01	1999-05-26	Kudos Pharm Ltd	Assays methods and means
JP2002541863A (ja) *	1999-04-21	2002-12-10	ワイス	Ｎ−型イオンチャンネル不活性化のモジュレーターを同定する方法
AU2001257157A1 (en) *	2000-04-24	2001-11-07	Wyeth	Novel cell systems having specific interaction of peptide binding pairs
EP1349946B1 (de)	2000-08-25	2011-01-26	BASF Plant Science GmbH	Polynukleotide, die für prenylproteasen aus pflanzen kodieren
AU2002220275A1 (en) *	2000-12-08	2002-06-18	The Board Of Trustees Of The University Of Illinois	Mutated class ii major histocompatibility proteins
PT1534819E (pt)	2002-08-21	2010-03-11	Revivicor Inc	Animais porcinos carecendo de qualquer expressão de alfa 1,3-galactosiltransferase funcional
US9453251B2 (en)	2002-10-08	2016-09-27	Pfenex Inc.	Expression of mammalian proteins in Pseudomonas fluorescens
US7285269B2 (en)	2002-12-02	2007-10-23	Amgen Fremont, Inc.	Antibodies directed to tumor necrosis factor
WO2005049804A2 (en) *	2003-11-17	2005-06-02	Georgia Tech Research Corporation	Engineering enzymes through genetic selection
EP1544307A1 (de) *	2003-12-18	2005-06-22	AXXAM S.r.l.	Chimärer LAC9 Rezeptor und dessen Verwendungen
EP2412816B1 (de)	2004-07-26	2014-12-03	Pfenex Inc.	Verfahren zur verbesserten Proteinexpression durch Strain-Engineering
CA2909775A1 (en)	2005-08-09	2007-03-29	Revivicor, Inc.	Transgenic ungulates expressing ctla4-ig and uses thereof
BRPI0707514A2 (pt) *	2006-02-07	2011-05-10	Wyeth Corp	mÉtodo de identificaÇço de um agente que module ossos ou um lipÍdio; mÉtodo de identificaÇço de um agente que module a atividade de norrin-frizzled4; kit para identificar um agente que module a atividade de lrp5-norrin-frizzled4; cÉlula ou linhagem celular desprovida de norrin nativo e que expresse uma lrp5 nço nativa e uma frizzled4 nço nativa
US9580719B2 (en)	2007-04-27	2017-02-28	Pfenex, Inc.	Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2615172A1 (de)	2007-04-27	2013-07-17	Pfenex Inc.	Schnellscreeningverfahren für Bakterienwirte zur Identifizierung bestimmter Stämme mit verbessertem Ertrag und/oder verbesserter Qualität bei der Expression heterologer Proteine
CN101131363B (zh) *	2007-09-30	2010-12-01	南京大学	一种基于酵母三杂交的小分子化合物检测方法
WO2016154452A2 (en)	2015-03-24	2016-09-29	Osiris Therapeutics, Inc.	Compositions comprising meniscal tissues and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5283173A (en) *	1990-01-24	1994-02-01	The Research Foundation Of State University Of New York	System to detect protein-protein interactions
US5322801A (en) *	1990-04-19	1994-06-21	The General Hospital Corporation	Protein partner screening assays and uses thereof
DE69333969T2 (de) *	1992-10-30	2006-09-14	The General Hospital Corp., Boston	Wechselwirkendes Fallensystem zur Isolierung von Proteinen
US5512473A (en) *	1993-01-29	1996-04-30	Brent; Roger	Max-interacting proteins and related molecules and methods
US5582995A (en) *	1993-06-11	1996-12-10	The General Hospital Corporation	Methods of screening for compounds which inhibit the direct binding of Ras to Raf
EP0743520A3 (de) *	1993-12-30	1999-11-10	The Salk Institute For Biological Studies	Neue Verwendungen von Gal4-Rezeptor-Konstruktionen
JP3468523B2 (ja) *	1994-01-21	2003-11-17	イコスコーポレイション	ガゼインキナーゼ▲ｉ▼と相互作用するタンパク質に関連する方法および物質
US5525490A (en) *	1994-03-29	1996-06-11	Onyx Pharmaceuticals, Inc.	Reverse two-hybrid method
US5691147A (en) *	1994-06-02	1997-11-25	Mitotix, Inc.	CDK4 binding assay

1994
- 1994-06-14 US US08/259,609 patent/US5989808A/en not_active Expired - Fee Related
1995
- 1995-05-31 NZ NZ287372A patent/NZ287372A/en not_active IP Right Cessation
- 1995-05-31 PT PT95920689T patent/PT765389E/pt unknown
- 1995-05-31 RU RU97100776/13A patent/RU2208646C2/ru not_active IP Right Cessation
- 1995-05-31 SI SI9520073A patent/SI9520073B/sl not_active IP Right Cessation
- 1995-05-31 AT AT95920689T patent/ATE245189T1/de not_active IP Right Cessation
- 1995-05-31 CA CA002195083A patent/CA2195083A1/en not_active Abandoned
- 1995-05-31 DE DE69531302T patent/DE69531302T2/de not_active Expired - Lifetime
- 1995-05-31 ES ES95920689T patent/ES2202366T3/es not_active Expired - Lifetime
- 1995-05-31 EP EP95920689A patent/EP0765389B1/de not_active Expired - Lifetime
- 1995-05-31 GE GEAP19953531A patent/GEP20022619B/en unknown
- 1995-05-31 DK DK95920689T patent/DK0765389T3/da active
- 1995-05-31 WO PCT/US1995/006895 patent/WO1995034646A1/en not_active Ceased
- 1995-05-31 AU AU26066/95A patent/AU706173B2/en not_active Ceased
- 1995-06-12 IL IL11411895A patent/IL114118A0/xx not_active IP Right Cessation
- 1995-06-13 ZA ZA954892A patent/ZA954892B/xx unknown
1997
- 1997-01-13 LT LT97-004A patent/LT4230B/lt not_active IP Right Cessation
- 1997-02-14 LV LVP-97-04A patent/LV11906B/en unknown
1999
- 1999-03-08 US US09/263,944 patent/US6251602B1/en not_active Expired - Fee Related
- 1999-05-06 US US09/305,483 patent/US6284519B1/en not_active Expired - Fee Related

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CUNNINGHAM, B. C. ET AL.: "Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule", SCIENCE, 1991, pages 821 - 825, XP000261650, DOI: doi:10.1126/science.1948064
LI JJ, HERSKOWITZ I.: "Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system", SCIENCE., 1993
S DAVIS ET AL.: "LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor", SCIENCE, 1993, pages 1805 - 1808
STATEN NR ET AL.: "Ligandspecific dimerization of the extracellular domain of the bovine growth hormone receptor.", J. BIOL. CHEM., 1993, pages 18 - 467

Also Published As

Publication number	Publication date
PT765389E (pt)	2003-11-28
SI9520073A (sl)	1998-02-28
LT97004A (en)	1997-07-25
EP0765389B1 (de)	2003-07-16
EP0765389A1 (de)	1997-04-02
US5989808A (en)	1999-11-23
DK0765389T3 (da)	2003-10-27
DE69531302D1 (de)	2003-08-21
ZA954892B (en)	1996-01-30
LV11906A (lv)	1997-12-20
CA2195083A1 (en)	1995-12-21
IL114118A0 (en)	1995-10-31
RU2208646C2 (ru)	2003-07-20
LV11906B (en)	1998-06-20
GEP20022619B (en)	2002-01-25
SI9520073B (sl)	2004-06-30
ATE245189T1 (de)	2003-08-15
ES2202366T3 (es)	2004-04-01
DE69531302T2 (de)	2004-04-22
AU2606695A (en)	1996-01-05
US6251602B1 (en)	2001-06-26
WO1995034646A1 (en)	1995-12-21
NZ287372A (en)	1997-11-24
US6284519B1 (en)	2001-09-04
AU706173B2 (en)	1999-06-10

Legal Events

Date

Code

Title

Description

2003-12-29

PD9A

Change of patent owner

Owner name: WYETH HOLDINGS CORPORATION, US

Effective date: 20031031

2012-01-25

MM9A

Lapsed patents

Effective date: 20110531

Publication	Publication Date	Title
LT4230B (en)	1997-10-27	Novel cell systems having specific interaction of peptide binding pairs
EP0371820B1 (de)	1996-07-31	Rezeptoren: ihre Identifizierung, Charakterisierung, Herstellung und Verwendung
Miesfeld	1989	The Structure and Function of Steroid Receptor Protein
US7122305B2 (en)	2006-10-17	Methods and compositions for identifying receptor effectors
WO1997008550A1 (en)	1997-03-06	Retinoid x receptors and components of the basal transcription machinery
EP1029915A2 (de)	2000-08-23	Expression von an G-Protein gekoppelten Rezeptoren in Hefe
US20030166143A1 (en)	2003-09-04	Methods and compositions for identifying receptor effectors
Ozenberger et al.	1995	Functional interaction of ligands and receptors of the hematopoietic superfamily in yeast
Ponticelli et al.	1995	The glutamine-rich activation domains of human Sp1 do not stimulate transcription in Saccharomyces cerevisiae
US6673540B1 (en)	2004-01-06	Cell systems having specific interaction of peptide binding pairs
EP1283870A1 (de)	2003-02-19	Neuartiges zellsystem mit spezifischer interaktion von peptidbindungspaaren
US20110136128A1 (en)	2011-06-09	Reporter assay screens for protein targets in saccharomyces cerevisiae
Yamaguchi et al.	1995	Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system
US7037656B2 (en)	2006-05-02	Methods and compositions for identifying ligands for nuclear receptors
US20030009022A1 (en)	2003-01-09	Methods and compositions for identifying receptor effectors
AU2003260308B2 (en)	2009-03-26	Method for identifying substances
Ozenberger	1997	Investigation of Ligand/Receptor
WO2003070975A2 (en)	2003-08-28	An estrogen receptor alpha construct for use in a yeast 2-hybrid assay
EP1261871A1 (de)	2002-12-04	Verfahren und zusammensetzungen zum identifizieren von liganden für kernrezeptoren
NO178704B (no)	1996-02-05	DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet
Cormack	1993	The TATA-binding protein: a mutational analysis
JP2005333812A (ja)	2005-12-08	Ｇｒのパーシャルアゴニストのスクリーニング方法